Display options
Cite
Bosetti R. Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?. Nanomedicine (Lond). 2015;10(12):1851-3doi: 10.2217/nnm.15.74.
Bosetti, R. (2015). Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?. Nanomedicine (London, England), 10(12), 1851-3. https://doi.org/10.2217/nnm.15.74
Bosetti, Rita. "Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?." Nanomedicine (London, England) vol. 10,12 (2015): 1851-3. doi: https://doi.org/10.2217/nnm.15.74
Bosetti R. Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?. Nanomedicine (Lond). 2015 Jul;10(12):1851-3. doi: 10.2217/nnm.15.74. PMID: 26139120.
Copy Download .nbib Format: NLM
Share it on

Nanomedicine (Lond). 2015 Jul;10(12):1851-3. doi: 10.2217/nnm.15.74.

Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?.

Nanomedicine (London, England)

Rita Bosetti

Affiliations

  1. Biomechanics Research Unit, University of Liège, Chemin des Chevreuils 1 - BAT 52/3 - BE4000 Liège, Belgium.

PMID: 26139120 DOI: 10.2217/nnm.15.74

[No abstract available.]

Keywords: challenges; commercialization; cost–effectiveness analysis; nanotherapeutics

MeSH terms

Publication Types